切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2022, Vol. 16 ›› Issue (05) : 468 -471. doi: 10.3877/cma.j.issn.1674-3253.2022.05.021

综述

腹腔镜保留肾单位手术治疗中央型肾癌的研究进展
刘宗毅1, 邵志强2, 刘子丰1, 许宗昱1, 郭丰富2,()   
  1. 1. 261001 山东,潍坊医学院临床医学院
    2. 276003 山东,临沂市人民医院泌尿外科
  • 收稿日期:2021-10-19 出版日期:2022-10-01
  • 通信作者: 郭丰富

Progress in laparoscopic nephron-sparing surgery for central renal cancer

Zongyi Liu1, Zhiqiang Shao2, Zifeng Liu1   

  • Received:2021-10-19 Published:2022-10-01
引用本文:

刘宗毅, 邵志强, 刘子丰, 许宗昱, 郭丰富. 腹腔镜保留肾单位手术治疗中央型肾癌的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(05): 468-471.

Zongyi Liu, Zhiqiang Shao, Zifeng Liu. Progress in laparoscopic nephron-sparing surgery for central renal cancer[J]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(05): 468-471.

肾肿瘤是临床上较为常见的一种泌尿系统肿瘤,约占成人恶性肿瘤的2%~3%[1]。我国属于肾癌低发病国家,但是近年来,我国肾肿瘤的发病率呈逐年升高的趋势[2]。外科手术是临床肾癌治疗的首选方法,过去,临床上对肾肿瘤患者主要进行根治性肾切除术[3]。近些年来,随着技术的进步和观念的发展,以及对于肿瘤疾病"三早"理念的不断完善,肾癌的治疗开始从腹腔镜下根治术(laparoscopic radical surgery,LRN),逐渐发展至部分切除术,腹腔镜下肾部分切除术(laparoscopic partial nephrectomy,LNSS)已成为目前泌尿外科医师治疗<4 cm肾癌的金标准[4]。而对于中央型肾癌,即临近肾门,靠近肾脏主要血管和集合系统的肿瘤,约占肾癌的6.9%~10%。因为其定位比较困难,术中容易损伤大血管和集合系统,长期以来被视为腹腔镜保留肾单位手术的禁忌证。但是随着技术的进步和观念的发展,LNSS的临床适应证不断扩展[5]。许多中心也在腹腔镜下成功地完成了诸多中央型肾癌行保留肾单位的手术,但存在一些风险和问题,本文主要对LNSS治疗中央型肾癌的研究进展进行综述。

[1]
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in china: good or bad news from the 2018 global cancer statistics?[J]. Cancer Commun (Lond), 2019, 39(1): 22.
[2]
Pang C, Guan Y, Li H, et al. Urologic cancer in China[J]. Jpn J Clin Oncol, 2016, 46(6): 497-501.
[3]
Méjean A. Advancement in the treatment of renal carcinoma[J]. Nephrol Ther, 2017, 13(3): 154-159.
[4]
Power NE, Silberstein JL, Touijer K. Is laparoscopic partial nephrectomy already the gold standard for small renal masses?[J]. Arch Esp Urol, 2013, 66(1): 90-98.
[5]
Li M, Cheng L, Zhang H, et al. Laparoscopic and robotic-assisted partial nephrectomy: an overview of hot issues[J]. Urol Int, 2020, 104(9-10): 669-677.
[6]
Zhao PT, Richstone L, Kavoussi LR. Laparoscopic partial nephrectomy[J]. Int J Surg, 2016, 36(Pt C): 548-553.
[7]
Breau RH, Kapoor A, Nash DM, et al. Partial vs. radical nephrectomy and the risk of all-cause mortality, cardiovascular, and nephrological outcomes[J]. Can Urol Assoc J, 2020, 14(10): 337-345.
[8]
Gurram S, Kavoussi L. Laparoscopic partial nephrectomy[J]. J Endourol, 2020, 34(S1): S17-S24.
[9]
马潞林, 邱敏. 肾肿瘤腹腔镜手术治疗的难点与对策[J]. 临床泌尿外科杂志, 2014, 29(6): 463-467.
[10]
Qin B, Hu H, Lu Y, et al. Intraoperative ultrasonography in laparoscopic partial nephrectomy for intrarenal tumors[J]. PLoS One, 2018, 13(4): e0195911.
[11]
Perez-Ardavin J, Sanchez-Gonzalez JV, Martinez-Sarmiento M, et al. Surgical treatment of completely endophytic renal tumor: a systematic review[J]. Curr Urol Rep, 2019, 20(1): 3.
[12]
Hardesty DA, Thind H, Zabramski JM, et al. Safety, efficacy, and cost of intraoperative indocyanine green angiography compared to intraoperative catheter angiography in cerebral aneurysm surgery[J]. J Clin Neurosci, 2014, 21(8): 1377-1382.
[13]
Wang RJ, Tang J, Chen Y, et al. The clinical value of indocyanine green fluorescence navigation system for laparoscopic partial nephrectomy in the case of complex renal clear cell carcinoma (R.E.N.A.L score ≥7)[J]. J Cancer, 2021, 12(6): 1764-1769.
[14]
张树栋, 洪鹏, 王滨帅, 等. 吲哚菁绿标记的荧光实时显影技术在腹腔镜肾部分切除术中的应用[J]. 北京大学学报(医学版), 2020, 52(4): 657-662.
[15]
Harke NN, Mandel P, Witt JH, et al. Are there limits of robotic partial nephrectomy? TRIFECTA outcomes of open and robotic partial nephrectomy for completely endophytic renal tumors[J]. J Surg Oncol, 2018, 118(1): 206-211.
[16]
vAbdel RA, Chang KD, Alenzi MJ, et al. Robot-assisted partial nephrectomy for totally endophytic renal tumors: step by step standardized surgical technique and long-term outcomes with a median 59-month Follow-Up[J]. J Laparoendosc Adv Surg Tech A, 2019, 29(1): 1-11.
[17]
Minervini A, Mari A, Carini M. Editorial comment to robot-assisted laparoscopic versus open partial nephrectomy in patients with chronic kidney disease: a propensity score-matched comparative analysis of surgical outcomes[J]. Int J Urol, 2017, 24(7): 510.
[18]
Glybochko PV, Rapoport LM, Alyaev YG, et al. Multiple application of three-dimensional soft kidney models with localized kidney cancer: A pilot study[J]. Urologia, 2018, 85(3): 99-105.
[19]
Bernhard JC, Isotani S, Matsugasumi T, et al. Personalized 3D printed model of kidney and tumor anatomy: a useful tool for patient education[J]. World J Urol, 2016, 34(3): 337-345.
[20]
Hekman MCH, Rijpkema M, Langenhuijsen JF, et al. Intraoperative Imaging Techniques to Support Complete Tumor Resection in Partial Nephrectomy[J]. Eur Urol Focus, 2018, 4(6): 960-968.
[21]
杨启维, 干思舜, 叶剑青, 等. 3D打印结合3D腹腔镜在部分内生型肾癌保留肾单位手术中的临床应用研究[J].中华泌尿外科杂志, 2019, 40(5): 333-339.
[22]
Nadu A, Kleinmann N, Laufer M, et al. Laparoscopic partial nephrectomy for central tumors: analysis of perioperative outcomes and complications[J]. J Urol, 2009, 181(1): 42-47.
[23]
邵志强, 刘宗毅,杨渝,等.腹腔镜保留肾单位手术治疗肾门部肿瘤21例[J]. 感染、炎症、修复, 2020, 21(2): 109-110.
[24]
Gieraerts C, Vanhoutte E, Laenen A, et al. Safety and efficacy of embolotherapy for severe hemorrhage after partial nephrectomy[J]. Acta Radiol, 2020, 61(12): 1701-1707.
[25]
Peyton CC, Hajiran A, Morgan K, et al. Urinary leak following partial nephrectomy: a contemporary review of 975 cases[J]. Can J Urol, 2020, 27(1): 10118-10124.
[26]
曾胜, 白志杰, 李哲,等. 肾癌保留肾单位手术切缘阳性的研究进展[J]. 中华泌尿外科杂志, 2020, 41(7): 552-554.
[27]
Frank I, Colombo JR Jr, Rubinstein M, et al. Laparoscopic partial nephrectomy for centrally located renal tumors[J]. J Urol,2006,175(3 Pt 1): 849-852.
[28]
马潞林, 刘茁. 完全内生型肾肿瘤行腹腔镜肾部分切除术的术中定位、切缘阳性率和预后[J].现代泌尿外科杂志, 2017, 22(11): 815-817, 856.
[29]
毛卫林, 刘艳, 谭大清, 等. 后腹腔镜肾部分切除术后切缘阳性与阴性的预后研究[J]. 现代泌尿生殖肿瘤杂志, 2019, 11(2): 83-86.
[30]
Demirel HC, Çakmak S, Yavuzsan AH, et al. Prognostic factors for surgical margin status and recurrence in partial nephrectomy[J]. Int J Clin Pract, 2020, 74(10): e13587.
[31]
Minervini A, Campi R, Lane BR, et al. Impact of resection technique on perioperative outcomes and surgical margins after partial nephrectomy for localized renal masses: a prospective multicenter study[J]. J Urol, 2020, 203(3): 496-504.
[1] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[2] 李凯, 陈淋, 向涵, 苏怀东, 张伟. 一种U型记忆合金线在经脐单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 15-15.
[3] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[4] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[5] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[6] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[7] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[8] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[9] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[10] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[11] 唐健雄, 李绍杰. 不断推进中国腹腔镜疝手术规范化[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 591-594.
[12] 田文, 杨晓冬. 腹腔镜腹股沟疝修补术式选择及注意事项[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 595-597.
[13] 李涛, 陈纲, 李世拥. 腹腔镜下右侧腹股沟斜疝修补术(TAPP)[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 598-598.
[14] 易明超, 汪鑫, 向涵, 苏怀东, 张伟. 一种T型记忆金属线在经脐单孔腹腔镜胆囊切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 599-599.
[15] 易明超, 汪鑫, 向涵, 苏怀东, 张伟. 一种T型记忆金属线在经脐单孔腹腔镜胆囊切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 599-599.
阅读次数
全文


摘要